Is Imugene (ASX:IMU) In A Good Position To Deliver On Growth Plans?

Yahoo Finance18:12

Those Who Invested in Imugene (ASX:IMU) Five Years Ago Are up 361%

Yahoo FinanceApr 24 18:23

Broker Says This ASX Biotech Stock Could Almost Double in Value

If you're the type of investor that likes high risk-high reward investments, then read on.

The Motley FoolApr 23 00:56

Imugene Signs Deal to Sell Manufacturing Facility For $6 Million

Imugene (ASX:IMU) signed a deal to sell its manufacturing facility in North Carolina to contract development and manufacturing organization Kincell for a total of $6 million, according to a Tuesday fi

MT NewswiresApr 16 01:21

Imugene Commences Enrolment for Cholangiocarcinoma Expansion Study

Immuno-oncology company Imugene (ASX:IMU) said it has opened enrolment for its expansion study in patients with bile tract cancer or cholangiocarcinoma, according to a Monday filing with the Australia

MT NewswiresApr 14 22:40

Press Release: Imugene's Oncolytic Virotherapy VAXINIA and B Cell Immunotherapy HER-Vaxx Featured at the AACR Annual Meeting 2024

Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024 -- Oncolytic virus CF33-hNIS (VAXINIA) alone or in combination with KEYTRUDA

Dow JonesApr 9 11:00